MolNFT v1 · #125771 · protein
The structure of NT.BSPD6I nicking endonuclease with all cysteines mutated by serine residues at 0.19 nm resolution .
5LIZ · Nicking endonuclease N.BSPD6I: “The structure of NT.BSPD6I nicking endonuclease with all cysteines mutated by serine residues at 0.19 nm…”. X-ray diffraction, 1 ligand (PO4), 8 pockets (best druggability 0.76). MolNFT v1 #125771 on…
- PDB
- 5LIZ
- Type
- protein
- Length
- 584 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Nicking endonuclease N.BSPD6I
- UniProt
- Q8GCA3
- Ligands
- PO4
- Pockets
- 8 · best druggability 0.76
Structure
x-ray diffraction · 1 distinct chain · 60% helix, 9% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Nicking endonuclease N.BSPD6I | protein | 584 | 60% helix, 9% strand | Q8GCA3 |
Ligands and binding sites
- PO4 · Phosphate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 761 | 0.76 | 0.80 | 82 | empty |
| 2 | 274 | 0.52 | 0.75 | 29 | empty |
| 3 | 180 | 0.46 | 0.75 | 25 | empty |
| 4 | 57 | 0.41 | 0.81 | 16 | empty |
| 5 | 75 | 0.39 | 0.79 | 21 | empty |
Compared structures
- 5LIZ · The structure of Nt.BspD6I nicking endonuclease with all cysteines mutated by serine… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8GCA3
- Elsewhere: RCSB PDB 5LIZ · PDBe 5LIZ · UniProt Q8GCA3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.